OVARIAN CANCER (OVCA)
Clinical trials for OVARIAN CANCER (OVCA) explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CANCER (OVCA) trials appear
Sign up with your email to follow new studies for OVARIAN CANCER (OVCA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pre-surgery fitness program may boost recovery in frail cancer patients
Disease control Recruiting nowThis study tests a comprehensive health program (exercise, nutrition, and mental support) given before major cancer surgery. It includes 148 frail patients with pancreatic, ovarian, kidney, or bladder cancer. Some patients also receive chemotherapy before surgery. The goal is to …
Matched conditions: OVARIAN CANCER (OVCA)
Phase: PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated May 16, 2026 22:29 UTC
-
New hope for ovarian cancer patients resistant to current treatments
Disease control Recruiting nowThis study tests a drug called trastuzumab deruxtecan (T-DXd) in people with ovarian cancer that has come back after treatment with PARP inhibitors. The drug targets a protein called HER2 found on some cancer cells. About 116 adults with HER2-positive ovarian cancer will be rando…
Matched conditions: OVARIAN CANCER (OVCA)
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New drug KIVU-107 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new drug called KIVU-107 in people with advanced solid tumors that have stopped responding to standard treatments. The drug is designed to target and kill cancer cells while limiting harm to healthy cells. The main goals are to find the safest dose and check fo…
Matched conditions: OVARIAN CANCER (OVCA)
Phase: PHASE1 • Sponsor: Kivu Bioscience Inc. • Aim: Disease control
Last updated May 12, 2026 13:42 UTC